Identifying the link can lead to a crucial diagnosis
Hereditary ATTR amyloidosis is a rapidly progressive disease that may eventually rob patients of function—and their lives.1-4
Find out how you can help accelerate time to diagnosis.
A genetic screening option offered at no charge
Learn about Alnylam Act™
Resources for healthcare providers
Find additional information about identifying hATTR amyloidosis
Sign up to receive updates
Stay up-to-date on news about hATTR amyloidosis
By clicking submit, you certify that you are a US healthcare professional.
Your submission has been received.
Return to site
Links to all outside sites are provided as a reference for our visitors. Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.